Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Revolution Medicines Inc shares valued at $7,542,023 were sold by Horn Margaret A on Jan 07 ’26. At $100.56 per share, Horn Margaret A sold 75,000 shares. The insider’s holdings dropped to 141,053 shares worth approximately $17.1 million following the completion of this transaction.
Also, Anders Jack sold 10,000 shares, netting a total of over 980,000 in proceeds. Following the sale of shares at $98.00 each, the insider now holds 108,065 shares.
Before that, MARGARET A HORN had added 75,000 shares to its account. In a trade valued at $5,988,750, the Officer bought Revolution Medicines Inc shares for $79.85 each.
As published in their initiating research note from Wolfe Research on November 18, 2025, Revolution Medicines Inc [RVMD] has been an Outperform and the price target has been revised to $75. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in early November. As of October 21, 2025, Mizuho has initiated its “an Outperform” rating for RVMD.
Analyzing RVMD Stock Performance
On last trading session, Revolution Medicines Inc [NASDAQ: RVMD] rose 1.06% to $121.22. The stock’s lowest price that day was $118.15, but it reached a high of $122.1199 in the same session. During the last five days, there has been a surge of approximately 18.02%. Over the course of the year, Revolution Medicines Inc shares have jumped approximately 184.75%.
Is Revolution Medicines Inc subject to short interest?
Stocks of Revolution Medicines Inc saw a sharp steep in short interest on 2025-12-31 dropping by -1.48 million shares to 15.31 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 16.79 million shares. A decline of -9.65% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.62 of the overall float, the days-to-cover ratio (short ratio) decline to 6.62.
Which companies own the most shares of Revolution Medicines Inc (RVMD)?
In terms of Revolution Medicines Inc share price expectations, FactSet research, analysts set an average price target of 80 in the next 12 months, down nearly -33.31% from the previous closing price of $119.95. Analysts anticipate Revolution Medicines Inc stock to reach 147 by 2026, with the lowest price target being 73. In spite of this, 13 analysts ranked Revolution Medicines Inc stock as Buy at the end of 2026. On September 12, 2025, Raymond James assigned a price target of “a Strong buy” to the stock and resumed coverage with a $72.
